GeneChem Management Inc.
Overview
GeneChem Management Inc. is a prominent biotechnology venture capital firm headquartered in Montreal, Canada. With over $350 million in assets distributed across four funds—GeneChem Technologies, GeneChem Therapeutics, Agechem, and AmorChem—the firm has been actively investing in drug discovery and development companies since 1997. Their portfolio spans the United States, Canada, and Europe, reflecting a broad geographical focus. The firm's investment strategy emphasizes early-stage companies in the biotechnology sector, particularly those involved in drug discovery and development. GeneChem's approach combines innovative science with insightful management and collaborative investor syndicates to build successful companies. This strategy has led to investments in over 60 companies, establishing GeneChem as a leader in managing focused biotech funds. GeneChem's commitment to the biotechnology sector is evident through its substantial assets under management and its diverse portfolio. The firm's focus on early-stage investments in drug discovery and development aligns with its mission to foster innovation and growth in the life sciences industry.
Investment Focus
- Innovative science
- Experienced management
- Collaborative investor syndicate
Portfolio Companies
Reach GeneChem Management Inc. directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about GeneChem Management Inc.
What sectors does GeneChem Management Inc. invest in?
GeneChem Management Inc. invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Quebec, Canada. GeneChem Management Inc. is listed as a venture capital in the ConnectSafely investor database.
What stage does GeneChem Management Inc. invest at?
GeneChem Management Inc. backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 1M - 50M.
Which regions does GeneChem Management Inc. invest in?
GeneChem Management Inc. invests across United States, Canada and Europe.
What companies has GeneChem Management Inc. invested in?
GeneChem Management Inc.'s portfolio includes Mperia Therapeutics Inc., SemaThera Inc., Corbin Therapeutics Inc., SpecificiT Pharma Inc. and Eosinate Therapeutics Inc..
Last updated · Source: ConnectSafely investor database
